The Medical Research Council has reopened curiosity-driven research funding under a redesigned framework, a move that could reshape how UK scientists pursue investigator-led ideas across biomedical and health sciences.
A new structure for applicant-led research
According to UK Research and Innovation, MRC applicant-led funding opportunities will reopen on 7 April, while experimental medicine opportunities are set to open on 30 April. The council says the changes are intended to support ambitious research across disciplines, speed up decisions for many applicants, and widen participation in panel assessment.
The redesign also brings MRC’s applicant-led research funding boards together into a single College of Experts. The council says the new structure is meant to retain the full breadth of its remit, spanning biomedical and health sciences from molecules and cells to tissues, organs, physiological systems and human populations. UKRI announcement
What the council says is changing
MRC Executive Chair Professor Patrick Chinnery said the council used the pause to reform its process so it better reflects today’s research community questions. He said the goal is to advance knowledge, improve lives and drive growth by backing curiosity-driven science that deepens understanding of human disease mechanisms and supports precision prevention, early diagnosis and treatment.
The council also said targeted investments will help combine disciplines, technologies, methodologies and skills where needed to address important research questions. It added that it will monitor the impact of the new approach to make sure it delivers on its aims without unintended consequences.
What comes next for UK biomedical research
MRC’s first application shortlisting in 2026 is planned for July, with decisions expected in December. The council says the framework sits alongside fellowships, strategic programmes, translational research funding, MRC Centres of Research Excellence and its institutes, forming what it describes as an interconnected portfolio for curiosity-driven science.
The announcement also lists several 2026 funding opportunities, including the pre-clinical translational models hub, applicant-led research, new investigator and partnership grants, the NHS patient flow dementia challenge, experimental medicine stages one and two, MRC CoRE round four full application, and capacity building clinical research training fellowship. For UK researchers, the reopening marks an important signal that a key source of medical research support is moving back into active use after months of transition.
